我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

抗心律失常药物的致心律失常作用新认识（二）(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
1994年第2期
页码:
91-95
栏目:
综述
出版日期:
1994-03-01

文章信息/Info

Title:
-
作者:
徐成斌
北京医科大学人民医院心内科 北京 100034
Author(s):
-
关键词:
-
Keywords:
-
分类号:
-
DOI:
-
文献标识码:
-
摘要:
-
Abstract:
-

参考文献/References

［1］Rae AP．et a1．Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.JACC 1989：12：131.

［2］ The Cardiac Arrhythmia Suppression Trial(CAST)Inyestigators：Preliminary report:Effect of encainide and flecainide on mortality in a randomized trial of arrhythmic suppression after myocardial iufarction. N Engl J Mod 1989；321：406.

［3］Horowitz IN，et al，Proarrhythmia，arrhythmogenesis or aggravation of arrhythmia：A status report，1987．Am J Cardiol 1987：59：54E.

［4］Zipes DP．Proarrhythmic effects of antiarrhythmic drugs.Am J Cardiol 1987；59：26E.

［5］Morganroth J，et a1．Application of a frequency definition of ventricular proarrhythmia．Am J Cardiol 1987；59：97.

［6］Naccarelli GV,ed.Cardiac Arrhythmia:A practical approach.NY:Futura Publishing Co.1991；397～412.

［7］Velebit V,et al.AggraVation and provocation of ventricular arrhythramsby antiarrhythmic drugs．circulation l982；65(5)：886.

[8] Podrid PJ,et al.The role of exorcase testing in evaluation of arrhythmias．Am J Cardiol 1988；6 2：24H.

[9]Horowitz N，et a1.Proarrhythmic responsesduring electrophysiologic testing．Am J Cardiol 1987；5 9：45E.

[10]Stanton MS，et a1.Arrhythmogenic effects of antiarrhythmic drugs：A study of 506 patients treated for ventricular tachycardia or fibrillation.JACC 1989：14：209.

[11]Podrid PJ,et al.Aggrayation of arrhythmia by antiarrhythmic drugs．Am J Cardiol 1987；59：38E.

[12]DiBianco R，et al.Treatment of frequency ventricular arrhythmia with encainide assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies. Circulation 1982；65：1134.

[13] Brugada P，Wellens HJJ．Arrhythmogenesis of antiarrhythmic druge．Am J Cardiol 1988：61：1108.

[14]Surawicz B．Ventricular arrhythmias．Why iS it so difficult to find a pharmacologic cure?JACC 1989；14：(6)140l.

[15]Levine JH，et al，Mechanisms and risk factors for proarrhythmia with type IA compared with Ic antiarrhythmic drug therapy．Circulation 1989；80：1063.

[16]Minardo JD，et a1．Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy．N Engl J Med 1988；319：257.

[17]Horowitz LN．Prearrhythmia--Taking the bad with the good．N Engl J Mod 1988；319：304.

[18]Woosley RL，Roden DM．Pharmacologic causes of arrhythmogenic actions of antiarrhythmic drugs． Am J Cardiol 1987；59：19E.

[19]Morganroth J.Risk factors for the development of proarrhythmic events.Am J Csrdiol 1987;59:32E.

[20]Bigger JT，Sahar DI．Clinical types of proarrhythmic response to antiarrhythmic drugs．Am J Cardiol 1987：59：2E.

[21] Katritsis D，Carom AJ．Are antiarrhythmic drugs safe?Clin Cardiol 1990；13：49l.

[22] Podrid PJ．Aggravation of ventricular arrhythmia：A drug induced complication．Drugs 1985；29： 33.

[23]Ruskin JN，et al.Antiarrhythmic drugs：A possible cause of out-of-hospital cardiac arrest.N Engl，J Med 1983；309：1302.

［24］Myerburg RJ，et a1．Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolo1．Circulation 1989；80：1571.

备注/Memo

备注/Memo:
收稿 1992-07-l8 (续完）
更新日期/Last Update: 1994-03-01